<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896911414018</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896911414018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Coexistence of Primary Gastric Giant Cell–Rich Leiomyosarcoma and Gastrointestinal Stromal Tumor</article-title>
<subtitle>Report of a Very Rare Combination and Review of the Literature</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Insabato</surname><given-names>Luigi</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1066896911414018">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Masone</surname><given-names>Stefania</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911414018">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Campione</surname><given-names>Severo</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911414018">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Vigliar</surname><given-names>Elena</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911414018">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Staibano</surname><given-names>Stefania</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911414018">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tornillo</surname><given-names>Luigi</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1066896911414018">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896911414018"><label>1</label>University “Federico II,” Naples, Italy</aff>
<aff id="aff2-1066896911414018"><label>2</label>Universitatsspital, Basel, Switzerland</aff>
<author-notes>
<corresp id="corresp1-1066896911414018">Luigi Insabato, Department of Pathology, Faculty of Medicine, University “Federico II,” Via S. Pansini 5, 80131 Naples, Italy Email: <email>insabato@unina.it</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>1</issue>
<fpage>74</fpage>
<lpage>78</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Leiomyosarcoma is one of the most common types of soft tissue sarcoma, usually seen in deep soft tissues of the extremities and retroperitoneum. Leiomyosarcoma primarily involving the gastrointestinal tract is uncommon. This report presents a rare case of primary gastric giant cell-rich leiomyosarcoma associated with a gastrointestinal stromal tumor of the stomach in a 51-year-old man. The patient was alive with no evidence of recurrence 10 months later. To the authors’ knowledge, this association has not been previously reported.</p>
</abstract>
<kwd-group>
<kwd>Stomach</kwd>
<kwd>neoplasm</kwd>
<kwd>mesenchymal</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896911414018" sec-type="intro">
<title>Introduction</title>
<p>Gastrointestinal stromal tumor (GIST), albeit rare, is the most frequent mesenchymal tumor of the gastrointestinal tract.<sup><xref ref-type="bibr" rid="bibr1-1066896911414018">1</xref></sup> Primary gastric leiomyosarcoma is extremely rare, accounting for only 1% of all malignant gastric neoplasms.<sup><xref ref-type="bibr" rid="bibr2-1066896911414018">2</xref></sup> We present here a case of gastric giant cell–rich leiomyosarcoma associated with a GIST of the stomach. To our knowledge, this tumor combination has not been previously reported.Methods</p>
<p>A 51-year-old man was admitted in July 2010 to the Naples Hospital of the “Federico II” University Hospital, Naples, Italy, with severe asthenia, weight loss (4 kg in 1 month), and slight sideropenic anemia (Hb 10.5 g/dL, RBC 3 650 000/µL, serum iron 22 µg/dL) with a positive fecal occult blood test. On physical examination, there was central upper quadrant pain and reported epigastralgia. Carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 15-3. and α-fetoprotein levels were within normal limits. Esophagogastroscopy revealed a 3 cm ulcerated lesion beyond the cardias on the posterior wall of the stomach, with irregular borders and fibrin on its surface. Biopsies of the lesion yielded a diagnosis of severe inflammation, fibrin, and moderate to severe dysplasia. Total body computed tomography scan showed only a thickening of the posterior wall of the stomach on the little curve. At laparotomy, a firm mass was found in the posterior wall of the gastric fundus. A total gastrectomy with Roux-en-Y esophagojejunal anastomosis was performed. Postoperative course was uneventful. The patient was discharged on the 12th postoperative day. Regular follow-up using abdominal ultrasound and computed tomography scan revealed no tumor recurrence or metastasis at last follow-up 10 months later.</p>
<p>Tumor specimens were fixed in buffered formalin and embedded routinely for histological evaluation. Immunohistochemical stains were performed on 4-µm sections cut from paraffin blocks. A panel of immunostains, including antibodies against vimentin, CD117, CD34, desmin, smooth muscle actin, S100 protein, neuron-specific enolase, Ki-67, and CD68, was applied to representative sections of both tumors using the avidin–biotin complex technique (<xref ref-type="table" rid="table1-1066896911414018">Table 1</xref>).</p>
<table-wrap id="table1-1066896911414018" position="float">
<label>Table 1.</label>
<caption><p>Primary Antibodies Used for Immunophenotyping</p></caption>
<graphic alternate-form-of="table1-1066896911414018" xlink:href="10.1177_1066896911414018-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th align="left">Antibody</th>
<th align="center">Manufacturer</th>
<th align="center">Retrieval</th>
<th align="center">Dilution</th>
<th align="center">Method</th>
</tr>
</thead>
<tbody>
<tr>
<td>CD117</td>
<td>DAKO (Carpinteria, CA, USA)</td>
<td>Steam 120°C/3 min; citrate buffer pH 6</td>
<td>1:300</td>
<td>ABC</td>
</tr>
<tr>
<td>CD34</td>
<td>Oxoid</td>
<td>Microwave 98°C/30 min; citrate buffer pH 6</td>
<td>1:900</td>
<td>ABC</td>
</tr>
<tr>
<td>Desmin</td>
<td>DAKO (Carpinteria, CA, USA)</td>
<td>Cook 15 min; citrate buffer pH 6</td>
<td>1:200</td>
<td>ABC</td>
</tr>
<tr>
<td>SMA</td>
<td>Sigma (St Louis, MO, USA)</td>
<td>Microwave 80°C/30 min; citrate buffer pH 6</td>
<td>1:60000</td>
<td>ABC</td>
</tr>
<tr>
<td>S-100</td>
<td>DAKO (Carpinteria, CA, USA)</td>
<td>Microwave 80°C/30 min; citrate buffer pH 6</td>
<td>1:10000</td>
<td>ABC</td>
</tr>
<tr>
<td>NSE</td>
<td>DAKO (Carpinteria, CA, USA)</td>
<td>Cook 15 min; citrate buffer pH 6</td>
<td>1:8000</td>
<td>ABC</td>
</tr>
<tr>
<td>Vimentin</td>
<td>Boehringer Mannheim Biochemica (Mannheim, Germany)</td>
<td>Microwave 98°C/30 min; citrate buffer pH 6</td>
<td>1:10</td>
<td>ABC</td>
</tr>
<tr>
<td>CD68 (KP1)</td>
<td>DAKOPATTS (Glostrup, Denmark)</td>
<td>Microwave 80°C/30 min; citrate buffer pH 6</td>
<td>1:100</td>
<td>ABC</td>
</tr>
<tr>
<td>Ki67</td>
<td>DAKO (Carpinteria, CA, USA)</td>
<td>Microwave 98°C/60 min; citrate buffer pH 6</td>
<td>1:1600</td>
<td>ABC</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1066896911414018">
<p>Abbreviation: ABC, avidin–biotin complex; SMA, smooth muscle actin; NSE, neuron-specific enolase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section2-1066896911414018">
<title>Molecular Analysis</title>
<p>For mutational analysis, DNA was extracted from formalin-fixed paraffin-embedded tissue. First, a sequencing analysis of the exons 9, 11, 13, and 17 of the c-kit gene and of the exons 12, 14, and 18 of the pdgfra gene was carried out. The dideoxysequencing according to Sanger was used.<sup><xref ref-type="bibr" rid="bibr3-1066896911414018">3</xref></sup> Subsequently, a sequencing analysis of exon 15 of braf gene was also performed.</p>
</sec>
</sec>
<sec id="section3-1066896911414018" sec-type="results">
<title>Results</title>
<sec id="section4-1066896911414018">
<title>Histopathologic Findings</title>
<p>Gross examination of the total gastrectomy specimen showed an ulcerated tumor mass measuring 40 × 16 mm involving the gastric wall in the region of the gastric body. A firm, whitish, well-circumscribed nodule measuring 10 × 7 mm was also present on the serosal side.</p>
<p>Microscopically, the main tumor involved the mucosa, submucosa, and muscularis propria. It was composed of neoplastic spindle cells arranged in a fascicular pattern (<xref ref-type="fig" rid="fig1-1066896911414018">Figure 1A</xref>). These cells had slightly eosinophilic cytoplasm and pleomorphic nuclei with prominent nucleoli. Pleomorphism, and foci of necrotic tissue, along with high mitotic activity (3 mitoses per high-power field) were seen (<xref ref-type="fig" rid="fig1-1066896911414018">Figure 1B</xref>). Strikingly, a large number of irregularly scattered osteoclast-like giant cells (OGCs) were observed (<xref ref-type="fig" rid="fig1-1066896911414018">Figure 1C</xref>). These giant cells showed abundant, strongly eosinophilic, well-defined cytoplasm, with numerous small, round or ovoid nuclei and inconspicuous nucleoli (<xref ref-type="fig" rid="fig1-1066896911414018">Figure 1D</xref>). Moreover, a well-circumscribed nodular lesion, separated from the tumor mass by a thin layer of fibrous tissue was seen in the subserosal space. It was composed of fairly uniform neoplastic cells with epithelioid appearance and round nuclei with inconspicuous nucleoli; mitoses were not observed (<xref ref-type="fig" rid="fig2-1066896911414018">Figure 2A</xref>). Immunohistochemically, the larger tumor showed reactivity for vimentin and muscle actin and, focally, for desmin. It was negative for CD117, CD34, neuron-specific enolase, and S100 protein. The smaller subserosal nodule was strongly positive for CD117 (<xref ref-type="fig" rid="fig2-1066896911414018">Figure 2B</xref>), vimentin, and CD34, and negative for S100 protein, desmin, and actin. Ki-67 staining showed a high proliferative rate (50%) in the larger tumor and a low proliferative rate in the smaller one. The OGCs strongly reacted with CD68 but failed to stain with the myogenic markers. A diagnosis of giant cell–rich leiomyosarcoma of the stomach with a simultaneous incidental GIST was made.</p>
<fig id="fig1-1066896911414018" position="float">
<label>Figure 1.</label>
<caption><p>Histologic features of leiomyosarcoma</p>
<p>A, The tumor infiltrated the gastric wall. B, High-power field view of leiomyosarcoma showing significant mitotic activity. C, An evident number of osteoclast-like giant cells (OGCs) are seen. D, Spindle-shaped cells with a huge OGC.</p></caption>
<graphic xlink:href="10.1177_1066896911414018-fig1.tif"/>
</fig>
<fig id="fig2-1066896911414018" position="float">
<label>Figure 2.</label>
<caption><p>Coexistence of gastrointestinal stromal tumor (GIST) and leiomyosarcoma</p>
<p>A, GIST on the left and leiomyosarcoma on the right. B, GIST strongly positive for CD117. C, Section of the gastric wall showing a huge transmural infiltration by leiomyosarcoma and a small well-circumscribed subserosal GIST (arrow).</p></caption>
<graphic xlink:href="10.1177_1066896911414018-fig2.tif"/>
</fig>
</sec>
<sec id="section5-1066896911414018">
<title>Mutational Status</title>
<p>KIT exons 9, 11, 13 and 17, PDGFRA exons 12, 14 and 18, and BRAF exon 15 were of the wild type.</p>
</sec>
</sec>
<sec id="section6-1066896911414018" sec-type="discussion">
<title>Discussion</title>
<p>Mesenchymal tumors of the gastrointestinal tract may occur in any level, but most of those located in the small and large bowel show immunohistochemical evidence of smooth muscle differentiation. GISTs are enigmatic tumors, mostly occurring in the stomach and small intestine rarely involving rectum, and esophagus. In the past few decades, GIST has become a subject of great interest given the new insights derived from the discovery of its derivation from the interstitial cells of Cajal, of the invariable C-kit immunoreactivity, and of its sensitivity to a RTKs inhibitor drug.<sup><xref ref-type="bibr" rid="bibr4-1066896911414018">4</xref><xref ref-type="bibr" rid="bibr5-1066896911414018"/>-<xref ref-type="bibr" rid="bibr6-1066896911414018">6</xref></sup></p>
<p>Prior to the advent of KIT immunohistochemistry, the majority of GISTs were classified as leiomyosarcomas or leiomyomas on the basis of the histologic findings. In the gastrointestinal tract, true gastric leiomyosarcomas are very rare. This is a unique report of a primary gastric giant cell–rich leiomyosarcoma and a synchronous gastric GIST. Extraskeletal neoplasms containing OGCs are uncommon, and leiomyosarcomas with OCGs are fairly rare. Giant cell–rich leiomyosarcoma of soft tissues represents an unusual variant of malignant smooth muscle tumor characterized by the presence of numerous multinucleated giant cells. Recently, a series of 8 cases of a variant of soft tissue leiomyosarcoma with OGCs mimicking the giant cell variant of malignant fibrous histiocytoma was reported.<sup><xref ref-type="bibr" rid="bibr7-1066896911414018">7</xref></sup> This variant of leiomyosarcoma has also recently been recognized in the uterus.<sup><xref ref-type="bibr" rid="bibr8-1066896911414018">8</xref></sup> We described 4 cases of malignant stromal tumors with prominent OGCs in the gastrointestinal tract. Three were leiomyosarcomas (gastric, small intestine, colon), and 1 was an epithelioid GIST of the colon.<sup><xref ref-type="bibr" rid="bibr9-1066896911414018">9</xref></sup> The significance of OGCs in these tumors, as well as their mechanism of formation, remains obscure. Recently, it was proposed that these cells are formed from scattered tumor-associated macrophages by a receptor activator for nuclear factor κB ligand-dependent mechanism.<sup><xref ref-type="bibr" rid="bibr10-1066896911414018">10</xref></sup></p>
<p>Small incidental gastric GISTs have been found in more than 10% of patients who had gastroesophageal resections for carcinomas.<sup><xref ref-type="bibr" rid="bibr11-1066896911414018">11</xref></sup> Very recently, authors have described gastric micro GISTs (&lt;1 cm) in up to 20% to 30% of surgical pathology/autopsy specimens. The majority were benign, self-limiting proliferations of interstitial cells of Cajal precursors.<sup><xref ref-type="bibr" rid="bibr12-1066896911414018">12</xref></sup></p>
<p>The driving molecular event in most GISTs is an activating mutation of receptor tyrosine kinase KIT or PDGFRA. Recently, an alternative pathway has been suggested, involving BRAF.<sup><xref ref-type="bibr" rid="bibr3-1066896911414018">3</xref></sup> However, a small subset of GISTs are actually wild-type and are characterized by a very indolent course. They often are incidental findings during operative procedures and probably would never evolve to a clinically significant tumor, thus suggesting that in the oncogenetic pathway of GISTs some other molecular events are involved.</p>
<p>GISTs may coexist with different types of cancer, either synchronously or metachronously. Some years ago the occurrence of other malignancies in patients with GISTs was reported.<sup><xref ref-type="bibr" rid="bibr13-1066896911414018">13</xref></sup> The authors conducted a review of the literature and their own records for cases with sporadic GISTs associated with other malignancies, with emphasis on solid tumors. They found 518 cancers in 486 patients. Many different types of cancer were found; however, no leiomyosarcoma was found associated to GIST.</p>
<p>Moreover, recently, authors reported the coexistence of GISTs with other tumors. They found other neoplasms in 22 of 82 patients with GIST, with a tendency toward more common localization of a GIST in the small intestine in patients with other neoplasms than in patients with a GIST alone. The most common accompanying tumors were colorectal and gastric adenocarcinoma; others were adenomas, leiomyomas, myelogenous leukemia, and squamous cell carcinoma. No leiomyosarcoma was found associated to GIST—neither in their series nor in their review of the literature data.<sup><xref ref-type="bibr" rid="bibr14-1066896911414018">14</xref></sup></p>
<p>In a more recent work, the authors identified 101 patients with GIST, 14 of them having other non-GIST tumors associated: The most frequent were gastric and colorectal adenocarcinoma. Other sites involved were breast (ductal carcinoma), kidney (clear cell carcinoma), prostate (adenocarcinoma), endometrium (adenocarcinoma), ovary (adenocarcinoma), and adrenal gland (neuroblastoma).<sup><xref ref-type="bibr" rid="bibr15-1066896911414018">15</xref></sup></p>
<p>The coexistence of GISTs and other tumors, unrelated to a specific syndrome, such as the Carney triad, neurofibromatosis type 1, and familial GIST, has rarely been described in the literature. However, to the best of our knowledge, this is the first case of an association of an incidental, gastric GIST and gastric giant cell–rich leiomyosarcoma.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896911414018">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miettinen</surname><given-names>M</given-names></name>
<name><surname>Lasota</surname><given-names>J</given-names></name>
</person-group>. <article-title>Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis</article-title>. <source>Virchows Arch</source>. <year>2001</year>;<volume>438</volume>:<fpage>1</fpage>-<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr2-1066896911414018">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Howe</surname><given-names>JR</given-names></name>
<name><surname>Karnell</surname><given-names>LH</given-names></name>
<name><surname>Scott-Conner</surname><given-names>C</given-names></name>
</person-group>. <article-title>Small bowel sarcoma: analysis of survival from the National Cancer Data Base</article-title>. <source>Ann Surg Oncol</source>. <year>2001</year>;<volume>8</volume>:<fpage>496</fpage>-<lpage>508</lpage>.</citation>
</ref>
<ref id="bibr3-1066896911414018">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Agaimy</surname><given-names>A</given-names></name>
<name><surname>Terracciano</surname><given-names>LM</given-names></name>
<name><surname>Dirnhofer</surname><given-names>S</given-names></name>
<name><surname>Tornillo</surname><given-names>L</given-names></name>
<name><surname>Hartmann</surname><given-names>A</given-names></name>
<name><surname>Bihl</surname><given-names>MP</given-names></name>
</person-group>. <article-title>V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours</article-title>. <source>J Clin Pathol</source>. <year>2009</year>;<volume>62</volume>:<fpage>613</fpage>-<lpage>616</lpage>.</citation>
</ref>
<ref id="bibr4-1066896911414018">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Demetri</surname><given-names>GD</given-names></name>
<name><surname>von Meheren</surname><given-names>M</given-names></name>
<name><surname>Blanke</surname><given-names>CD</given-names></name>
<etal/>
</person-group>. <article-title>Efficacy and safety of imatinib masylate in advanced gastrointestinal stromal tumors</article-title>. <source>N Engl J Med</source>. <year>2002</year>;<volume>347</volume>:<fpage>472</fpage>-<lpage>480</lpage>.</citation>
</ref>
<ref id="bibr5-1066896911414018">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hirota</surname><given-names>S</given-names></name>
<name><surname>Isozaki</surname><given-names>K</given-names></name>
<name><surname>Moriyama</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors</article-title>. <source>Science</source>. <year>1998</year>;<volume>279</volume>:<fpage>577</fpage>-<lpage>580</lpage>.</citation>
</ref>
<ref id="bibr6-1066896911414018">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kindblom</surname><given-names>LG</given-names></name>
<name><surname>Remotti</surname><given-names>HE</given-names></name>
<name><surname>Aldenborg</surname><given-names>F</given-names></name>
<name><surname>Meis-Kindblom</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cell of Cajal</article-title>. <source>Am J Pathol</source>. <year>1998</year>;<volume>152</volume>:<fpage>1259</fpage>-<lpage>1269</lpage>.</citation>
</ref>
<ref id="bibr7-1066896911414018">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mentzel</surname><given-names>T</given-names></name>
<name><surname>Calonje</surname><given-names>E</given-names></name>
<name><surname>Fletcher</surname><given-names>CD</given-names></name>
</person-group>. <article-title>Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma</article-title>. <source>Am J Surg Pathol</source>. <year>1994</year>;<volume>18</volume>: <fpage>258</fpage>-<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr8-1066896911414018">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>KTK</given-names></name>
</person-group>. <article-title>Leiomyosarcoma with osteoclast-like giant cells</article-title>. <source>Am J Surg Pathol</source>. <year>1995</year>;<volume>19</volume>:<fpage>487</fpage>-<lpage>488</lpage>.</citation>
</ref>
<ref id="bibr9-1066896911414018">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Insabato</surname><given-names>L</given-names></name>
<name><surname>Di Vizio</surname><given-names>D</given-names></name>
<name><surname>Ciancia</surname><given-names>G</given-names></name>
<name><surname>Pettinato</surname><given-names>G</given-names></name>
<name><surname>Tornillo</surname><given-names>L</given-names></name>
<name><surname>Terracciano</surname><given-names>L</given-names></name>
</person-group>. <article-title>Malignant gastrointestinal leiomyosarcoma and gastrointestinal stromal tumor with prominent osteoclast-like giant cells</article-title>. <source>Arch Pathol Lab Med</source>. <year>2004</year>;<volume>128</volume>: <fpage>440</fpage>-<lpage>443</lpage>.</citation>
</ref>
<ref id="bibr10-1066896911414018">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gibbons</surname><given-names>CL</given-names></name>
<name><surname>Sun</surname><given-names>SG</given-names></name>
<name><surname>Vlychou</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Osteoclast-like cells in soft tissue leiomyosarcomas</article-title>. <source>Virchows Arch</source>. <year>2010</year>; <volume>456</volume>:<fpage>317</fpage>-<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr11-1066896911414018">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abraham</surname><given-names>SC</given-names></name>
<name><surname>Krasinskas</surname><given-names>AM</given-names></name>
<name><surname>Hofstetter</surname><given-names>WL</given-names></name>
<name><surname>Swisher</surname><given-names>SG</given-names></name>
<name><surname>Wu</surname><given-names>TT</given-names></name>
</person-group>. <article-title>Seedling mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common in the esophagogastric region</article-title>. <source>Mod Pathol</source>. <year>2006</year>;<volume>19</volume>:<fpage>100A</fpage>.</citation>
</ref>
<ref id="bibr12-1066896911414018">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rossi</surname><given-names>S</given-names></name>
<name><surname>Gasparotto</surname><given-names>D</given-names></name>
<name><surname>Toffolatti</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size</article-title>. <source>Am J Surg Pathol</source>. <year>2010</year>; <volume>34</volume>:<fpage>1480</fpage>-<lpage>1491</lpage>.</citation>
</ref>
<ref id="bibr13-1066896911414018">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Agaimy</surname><given-names>A</given-names></name>
<name><surname>Wünsch</surname><given-names>PH</given-names></name>
<name><surname>Sobin</surname><given-names>LH</given-names></name>
<name><surname>Lasota</surname><given-names>J</given-names></name>
<name><surname>Miettinen</surname><given-names>M</given-names></name>
</person-group>. <article-title>Occurrence of other malignancies in patients with gastrointestinal stromal tumors</article-title>. <source>Semin Diagn Pathol</source>. <year>2006</year>;<volume>23</volume>: <fpage>120</fpage>-<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr14-1066896911414018">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liszka</surname><given-names>L</given-names></name>
<name><surname>Zielinska-Pajak</surname><given-names>E</given-names></name>
<name><surname>Pajak</surname><given-names>J</given-names></name>
<name><surname>Golka</surname><given-names>D</given-names></name>
<name><surname>Huszno</surname><given-names>J</given-names></name>
</person-group>. <article-title>Coexistence of gastrointestinal stromal tumors with other neoplasms</article-title>. <source>J Gastroenterol</source>. <year>2007</year>;<volume>42</volume>:<fpage>641</fpage>-<lpage>649</lpage>.</citation>
</ref>
<ref id="bibr15-1066896911414018">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goncalves</surname><given-names>R</given-names></name>
<name><surname>Linhares</surname><given-names>E</given-names></name>
<name><surname>Albagli</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Occurrence of other tumors in patients with GIST</article-title>. <source>Surg Oncol</source>. <year>2010</year>;<volume>6</volume>:<fpage>1</fpage>-<lpage>4</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>